NEW
Ferinject

Ferinject

ferric carboxymaltose

Manufacturer:

Zuellig Pharma

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Ferric carboxymaltose
Indications/Uses
Fe deficiency when oral Fe prep are ineffective or cannot be used, or where there is clinical need to deliver Fe rapidly.
Dosage/Direction for Use
Single max dose: 15 mg Fe/kg IV inj or 20 mg Fe/kg IV infusion. Max recommended cumulative dose: 1,000 mg Fe wkly. Individualized dosage based on patient's body wt & Hb level. Haemodialysis-dependent chronic kidney disease Single max dose: 200 mg Fe daily.
Contraindications
Hypersensitivity to ferric carboxymaltose & other parenteral Fe products. Anaemia not attributed to Fe deficiency eg, other microcytic anaemia. Evidence of Fe overload or utilisation disturbances.
Special Precautions
Discontinue use if hypersensitivity reactions or signs of intolerance occur; in patients w/ ongoing bacteraemia. Not to be inj SC or IM. History of severe asthma, eczema or other atopic allergy. Patients w/ immune or inflammatory conditions eg, SLE, RA; acute or chronic infection; hypophosphataemia. Avoid paravenous leakage at inj site. Patients on Na-controlled diet. Avoid use in patients w/ hepatic dysfunction. Not to be used during pregnancy. Not recommended in childn <14 yr.
Adverse Reactions
Hypophosphataemia; headache, dizziness; flushing, HTN; nausea; inj/infusion site reactions.
Drug Interactions
ATC Classification
B03AC - Iron, parenteral preparations ; Used in the treatment of anemia
Presentation/Packing
Form
Ferinject soln for inj/infusion 50 mg/mL
Packing/Price
10 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in